InpharmD
YC W21Atlanta, US · Founded 2018 · 16 employees · 7 known investors
InPharmD is a medical literature research platform that analyzes published studies to answer clinical pharmacology questions, specifically focused on adverse drug reactions and medication safety.
AI & Machine LearningDigital HealthHealthtechArtificial IntelligenceB2BTelemedicineUnited States of AmericaAmerica / CanadaPartly Remote
Founders & leadership· Y Combinator alumni (W21)
InpharmD was founded in 2018 by Ashish Advani and Tulasee Rao Chintha.
AA
Ashish Advaniin𝕏FounderAshish Advani holds a PharmD from the University of Georgia and studied at Oxford University. He has spent a decade as a clinical pharmacist specializing in drug information at Atlanta Medical Center and previously directed a drug information center at Mercer University College of Pharmacy.
TR
Tulasee Rao Chinthain𝕏Chief Technology Officer | Co-FounderTulasee Rao Chintha holds a Bachelor of Technology from Jawaharlal Nehru Technological University in India and brings over a decade of full-stack software development experience, including 10 years as an architect at Resource Logistics Inc and 5 years as a senior engineer at TCS, with expertise in artificial intelligence, cloud infrastructure, and IoT systems.
Investors · 7
645 VenturesNew York · $1M – $5M
Asymmetry VenturesRichmond · $125K – $500Kvia Rob Ness · inferred
Atlanta Tech VillageAtlanta
Y CombinatorSan Francisco · $500K
Also in the syndicate · 3
Atlanta VenturesQlarant CapitalSF ELC
Funding
SEC filings, press & company announcements$6M disclosed across 1 of 2 rounds · 2023
- Undisclosed amountSeries SeedDec 2023
645 Ventures (lead), Atlanta Ventures, Qlarant Capital, SF ELC, Y Combinator
Source ↗ - $6MraisedDec 2023 · 2 sources
645 Ventures (lead), Atlanta Ventures, Qlarant Capital, SF ELC, Y Combinator
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Competitors · 2
by search overlap
Medscape1413 shared keywordsMedscape is an online medical information platform providing clinical news, expert perspectives, case studies, quizzes, and reference material across specialties such as cardiology, oncology, neurology, and psychiatry. It serves physicians, nurses, pharmacists, residents, and medical students.
Oup507 shared keywordsOxford University Press publishes research, educational, and reference materials, including reports on reading and children's learning, and reference resources such as its dictionary "Word of the Day." It serves readers, educators, and learners across a wide range of subjects worldwide.
Companies competing with InpharmD for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does InpharmD do?
- InPharmD is a medical literature research platform that analyzes published studies to answer clinical pharmacology questions, specifically focused on adverse drug reactions and medication safety.
- Who founded InpharmD?
- InpharmD was founded by Ashish Advani, Tulasee Rao Chintha in 2018.
- Who are InpharmD's investors?
- InpharmD's investors include 645 Ventures, Asymmetry Ventures, Atlanta Tech Village, Y Combinator.
- How much funding has InpharmD raised?
- InpharmD has disclosed $6M raised across 1 of its 2 known rounds.
- Where is InpharmD headquartered?
- InpharmD is headquartered in Atlanta, US.